Arylimidamides Have Potential for Chemoprophylaxis against Blood-Transmitted Chagas Disease

Arylimidamides Have Potential for Chemoprophylaxis against Blood-Transmitted Chagas Disease

Chagas disease (CD) affects over 6 million people worldwide and can be transmitted iatrogenically. Crystal violet (CV) was previously used for pathogen reduction but has harmful side-effects. In the present study, three arylimidamides (AIAs) and CV were used to sterilize mice blood samples experimen...

Full description

Bibliographic Details
Main Authors: Bruno Lisboa Timm, Aline Nefertiti Silva da Gama, Marcos Meuser Batista, Denise da Gama Jaén Batista, David W. Boykin, Harry P. De Koning, Maria de Nazaré Correia Soeiro
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pathogens
Subjects:
<i>Trypanosoma cruzi</i>
blood bank
arylimidamides
chemoprophylaxis
Chagas disease
Online Access:https://www.mdpi.com/2076-0817/12/5/701

Similar Items

Similar Items